In the evolving landscape of antiviral therapy, certain compounds stand out for their significant impact on patient care and disease management. Among these, Valganciclovir Hydrochloride, identified by its CAS 175865-59-5, has carved a niche as a cornerstone treatment for Cytomegalovirus (CMV) infections. Its introduction marked a considerable advancement over its parent compound, ganciclovir, primarily due to its enhanced oral bioavailability, which translates to more convenient and effective administration for patients.
The unique Valganciclovir mechanism of action antiviral lies in its nature as a prodrug. Once administered, it is rapidly converted into ganciclovir, which then acts as a potent inhibitor of viral DNA polymerase. This targeted action prevents the replication of CMV, thereby controlling the infection and mitigating its severe consequences, such as CMV retinitis in AIDS patients or systemic CMV disease in organ transplant recipients. This targeted approach minimizes impact on host cells while powerfully combating the virus.
Research continues to explore the full potential of Valganciclovir in antiviral drug development. Scientists are investigating new formulations and combination therapies to further optimize its efficacy and reduce potential side effects. The availability of high-quality Valganciclovir Hydrochloride from reputable sources like NINGBO INNO PHARMCHEM CO.,LTD. is crucial for ongoing clinical trials and the production of life-saving medications. Ensuring a steady supply of this critical API is paramount for global health initiatives.
For pharmaceutical companies and researchers looking to buy Valganciclovir HCl bulk, understanding its pharmacokinetic profile is key. The improved absorption means that lower oral doses can achieve therapeutic concentrations comparable to intravenous ganciclovir, offering significant advantages in patient compliance and healthcare costs. NINGBO INNO PHARMCHEM CO.,LTD. supports innovation by providing access to this essential compound, enabling the development of next-generation antiviral solutions. This commitment to quality and accessibility underpins advancements in treating complex viral diseases.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.